Why Are GLP-1 Medications Helping So Many Different Medical Conditions? For years, GLP-1 medications such as semaglutide (Wegovy®, Ozempic®) and tirzepatide (Zepbound®, Mounjaro®) were viewed primarily as weight-loss or diabetes medications. Today, researchers are...
The short answer is generally no. If you already receive coverage for a GLP-1 medication such as Ozempic® through your Medicare Part D prescription drug plan for Type 2 diabetes, you generally cannot switch to the Medicare GLP-1 Bridge Program. The Bridge Program was...
A Review of the Science Behind Medicare’s New Approach to Obesity Treatment and Cardiovascular Disease Prevention Beginning in July 2026, the Centers for Medicare & Medicaid Services (CMS) launched the Medicare GLP-1 Bridge Program, a temporary demonstration...
Published by DPC Medical-Dodson Pain Consultants, PA For millions of Americans, managing obesity and weight-related health conditions has been challenging—not only because of the complexity of weight loss itself, but also because of the cost of newer prescription...
Beyond Weight Loss: 7 Health Benefits of Tirzepatide You Should Know About Most people have heard about Tirzepatide because of its impressive weight-loss results. However, recent research suggests that Tirzepatide may provide benefits far beyond the number on the...
